CAPNEA 20MG INJECTION is used in neonatal care to treat apnea of prematurity, a condition where premature infants stop breathing for short periods. This injection helps stimulate the respiratory center, improving breathing patterns and supporting healthy oxygen levels in newborns.

CAPNEA 20MG INJECTION is administered in hospitals and neonatal intensive care units under medical supervision. It helps reduce apnea episodes, supports stable breathing, and assists healthcare providers in managing respiratory complications in premature babies safely and effectively.

CAPNEA 20MG INJECTION is a trusted pharmaceutical solution used in advanced neonatal care worldwide. These products provide consistent quality, reliable performance, and effective respiratory support, making them essential pharmaceutical treatments for premature infant care.

Product Features

• Used for apnea of prematurity treatment.
• Stimulates breathing in premature infants.
• Administered under medical supervision.
• Supports neonatal ICU respiratory care.
• Provides reliable therapeutic results.

How It Helps

• Reduces apnea episodes in newborns.
• Improves breathing stability.
• Supports oxygen level balance.
• Aids respiratory development.